✨ Medicines Consent Notices




1 MAY 2014 NEW ZEALAND GAZETTE, No. 44 1291

Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Isuprel

Active Ingredient: Isoprenaline hydrochloride 200mcg/mL

Dosage Form: Solution for injection

New Zealand Sponsor: Hospira NZ Limited

Manufacturers:

  • Abbott Laboratories Srl, Latina, Italy
  • Hospira SpA, Milano, Italy
  • Hospira Inc, Kansas, United States of America

Dated this 24th day of April 2014.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

go2595

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Escitalopram

Active Ingredient: Escitalopram oxalate 6.388mg equivalent to Escitalopram 5mg

Dosage Form: Film coated tablet

New Zealand Sponsor: Air Flow Products Limited

Manufacturer: Intas Pharmaceuticals Limited, Gujarat, India

Product: Escitalopram

Active Ingredient: Escitalopram oxalate 12.776mg equivalent to Escitalopram 10mg

Dosage Form: Film coated tablet

New Zealand Sponsor: Air Flow Products Limited

Manufacturer: Intas Pharmaceuticals Limited, Gujarat, India

Product: Escitalopram

Active Ingredient: Escitalopram oxalate 25.552mg equivalent to Escitalopram 20mg

Dosage Form: Film coated tablet

New Zealand Sponsor: Air Flow Products Limited

Manufacturer: Intas Pharmaceuticals Limited, Gujarat, India

Product: Montelukast Actavis 4

Active Ingredient: Montelukast sodium 4.16mg equivalent to Montelukast 4mg

Dosage Form: Chewable tablet

New Zealand Sponsor: Actavis New Zealand Limited

Manufacturer: Intas Pharmaceuticals Limited, Gujarat, India

Product: Montelukast Actavis 5

Active Ingredient: Montelukast sodium 5.2mg equivalent to Montelukast 5mg

Dosage Form: Chewable tablet

New Zealand Sponsor: Actavis New Zealand Limited

Manufacturer: Intas Pharmaceuticals Limited, Gujarat, India

Product: Montelukast Actavis 10

Active Ingredient: Montelukast sodium 10.4mg equivalent to Montelukast 10mg

Dosage Form: Film coated tablet

New Zealand Sponsor: Actavis New Zealand Limited

Manufacturer: Intas Pharmaceuticals Limited, Gujarat, India



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2014, No 44





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of a New Medicine - Isuprel

πŸ₯ Health & Social Welfare
24 April 2014
Medicines, Distribution, Isuprel, Isoprenaline hydrochloride, Hospira NZ Limited
  • DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health

πŸ₯ Consent to the Distribution of New Medicines - Escitalopram and Montelukast

πŸ₯ Health & Social Welfare
24 April 2014
Medicines, Distribution, Escitalopram, Montelukast, Air Flow Products Limited, Actavis New Zealand Limited
  • DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health